Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 3, 2025
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-02$28.08/sh−548$15,386→ 53,657 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on August 29, 2025.